Molecular Tumor Board Provides Useful Assist in Cancer Precision Medicine
Study Finds Racial Inequities in Access to Opioids Among Older Patients With Cancer Near End of Life
Three-Drug Combination Therapy Effective in Patients with High-Risk CLL, Trial Shows
New Receptor “Decoy” Drug Neutralizes COVID-19 Virus and Its Variants
Research With a Worldwide Reach
Mount Sinai Researcher Receives Prestigious Award From the Asbestos Disease Awareness Organization
Preventing Fractures in the Bone Mets Population
A Leading-Edge Lymphoma Program
Paper Proposes New Community-Oriented Fellowship Training Model for Hematologists/Oncologists
Clinical Trial of Roswell Park’s SurVaxM Glioblastoma Vaccine Reveals Promising Results
Study Finds That Risk of Adverse Side Effects From Cancer Immunotherapy is Higher in Patients with Certain Inherited Genetic Variations
Roswell Park Chief of Leukemia Presents Findings of Acute Myeloid Leukemia Study at ASH Annual Meeting
Next-Generation Drug Improves Progression-Free Survival in Relapsed Chronic Lymphocytic Leukemia
New Clinical Tool for Clonal Hematopoiesis Identifies Patients at High Risk for Blood Cancer
Experimental Cancer Therapy Shows Success in More Than 70 Percent of Patients in Global Clinical Trials
Showing 361 - 375 of 1049 results
Previous| 1... 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 ...70 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
